Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina L Fanola

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Vascular Health and Risk Management|June 12, 2015
Current and emerging strategies in the management of venous thromboembolism: benefit-risk assessment of dabigatranChristina L Fanola
Current Treatment Options in Cardiovascular Medicine|November 14, 2018
Vascular Genetics: Presentations, Testing, and PrognosticsAaron W Aday, Sarah E Kreykes, Christina L Fanola
American Heart Journal|February 23, 2017
Incidence of severe renal dysfunction among individuals taking warfarin and implications for non-vitamin K oral anticoagulantsChristina L Fanola, Deirdre Mooney, Andrew J Cowan, et al.
European Heart Journal|January 9, 2017
A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trialChristina L Fanola, Robert P Giugliano, Christian T Ruff, et al.
Journal of the American College of Cardiology|January 18, 2020
Incident Heart Failure and Long-Term Risk for Venous ThromboembolismChristina L Fanola, Faye L Norby, Amil M Shah, et al.
European Heart Journal|February 3, 2018
Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular riskBrian A Bergmark, Benjamin M Scirica, Ph Gabriel Steg, et al.
Journal of the American Heart Association|October 26, 2017
Interleukin-6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib-Thrombolysis in Myocardial Infarction 52) TrialChristina L Fanola, David A Morrow, Christopher P Cannon, et al.
Journal of Vascular Surgery|January 7, 2019
Decreased mortality with local versus general anesthesia in endovascular aneurysm repair for ruptured abdominal aortic aneurysm in the Vascular Quality Initiative databaseRumi Faizer, Eric Weinhandl, Selma El Hag, et al.
Journal of the American Heart Association|October 30, 2018
Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF - TIMI 48 TrialChristina L Fanola, Christian T Ruff, Sabina A Murphy, et al.
Clinical Cardiology|August 1, 2018
TIMI-AF score and cardiovascular events in vitamin K antagonists-naïve outpatients with atrial fibrillationAlejandro Isidoro Pérez Cabeza, Rafael Bravo Marques, Pedro Antonio Chinchurreta Capote, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Vascular Health and Risk Management|June 12, 2015
Current and emerging strategies in the management of venous thromboembolism: benefit-risk assessment of dabigatranChristina L Fanola
Current Treatment Options in Cardiovascular Medicine|November 14, 2018
Vascular Genetics: Presentations, Testing, and PrognosticsAaron W Aday, Sarah E Kreykes, Christina L Fanola
American Heart Journal|February 23, 2017
Incidence of severe renal dysfunction among individuals taking warfarin and implications for non-vitamin K oral anticoagulantsChristina L Fanola, Deirdre Mooney, Andrew J Cowan, et al.
European Heart Journal|January 9, 2017
A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trialChristina L Fanola, Robert P Giugliano, Christian T Ruff, et al.
Journal of the American College of Cardiology|January 18, 2020
Incident Heart Failure and Long-Term Risk for Venous ThromboembolismChristina L Fanola, Faye L Norby, Amil M Shah, et al.
European Heart Journal|February 3, 2018
Blood pressure and cardiovascular outcomes in patients with diabetes and high cardiovascular riskBrian A Bergmark, Benjamin M Scirica, Ph Gabriel Steg, et al.
Journal of the American Heart Association|October 26, 2017
Interleukin-6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib-Thrombolysis in Myocardial Infarction 52) TrialChristina L Fanola, David A Morrow, Christopher P Cannon, et al.
Journal of Vascular Surgery|January 7, 2019
Decreased mortality with local versus general anesthesia in endovascular aneurysm repair for ruptured abdominal aortic aneurysm in the Vascular Quality Initiative databaseRumi Faizer, Eric Weinhandl, Selma El Hag, et al.
Journal of the American Heart Association|October 30, 2018
Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF - TIMI 48 TrialChristina L Fanola, Christian T Ruff, Sabina A Murphy, et al.
Clinical Cardiology|August 1, 2018
TIMI-AF score and cardiovascular events in vitamin K antagonists-naïve outpatients with atrial fibrillationAlejandro Isidoro Pérez Cabeza, Rafael Bravo Marques, Pedro Antonio Chinchurreta Capote, et al.
Pageof 2